Nick Paul TaylorArtificial IntelligenceAI concurs with humans in heart failure test, suggesting scalable approach to clinical trialsArtificial intelligence (AI) may make clinical trials more efficient by accurately identifying events at scale, a retrospective analysis has found.November 21, 2023Regulatory ApprovalFDA plans to increase oversight of LDTs garner strong responsePlans to increase U.S. Food and Drug Administration (FDA) oversight of laboratory-developed tests (LDTs) have drawn a strong response from trade groups, individuals, and organizations.November 17, 2023BiosensorsNetworks of wearable sensors capture body sounds to improve patient monitoringResearchers have developed soft, miniaturized wearable devices to continuously capture the sounds of breathing and other bodily functions.November 16, 2023Breast CancerFragment of C. diff toxin shows preclinical promise as breast cancer treatmentA fragment of a Clostridium difficile toxin could improve outcomes in patients with hard-to-treat forms of breast cancer, according to a paper published in PLOS Biology.November 13, 2023SequencingBlood test for biomarker offers route to affordable cancer screeningResearchers have developed a sensitive blood test for a highly specific biomarker of multiple common tumors, laying the groundwork for a product that could improve cancer screening.November 6, 2023SequencingOxford Nanopore partners with Fabric Genomics on assessment of genetic disease in childrenOxford Nanopore Technologies and Fabric Genomics have teamed up to provide a sequencing analysis platform for neonatal and pediatric intensive care units.November 1, 2023Gene silencing and gene editingSoftware reduces DANGER of CRISPR-Cas9 by shedding light on off-target editsA new software can improve the safety and utility of CRISPR-Cas9 gene editing by detecting off-target changes and eliminating the need for reference genomes, according to a paper published in Bioinformatics Advances.October 27, 2023SequencingPharma companies back project to create largest African ancestry genomics research databaseAstraZeneca, Novo Nordisk, Regeneron, and Roche have backed a project to create the largest African ancestry genomics research database.October 25, 2023SequencingSanger Institute starts program to make biology as easy to engineer as softwareThe Wellcome Sanger Institute has begun a research program to empower scientists to engineer biology as easily as software, electronics, and cars.October 23, 2023Lawsuit23andMe accused of ‘reckless’ practices as data leak triggers class action lawsuit23andMe faces a class action lawsuit for allegedly failing to use “adequate and reasonable cyber-security procedures” that could have prevented a data leak.October 16, 2023Previous PagePage 3 of 17Next PageTop StoriesFDA ClearanceAmgen gets FDA approval for small cell lung cancer therapyAmgen announced on Thursday that the U.S. Food and Drug Administration (FDA) has approved its therapy tarlatamab, to be marketed under the name Imdelltra, for the treatment of extensive-stage small cell lung cancer (ES-SCLC).Mergers & AcquisitionsVector Laboratories merges with Absolute BiotechArtificial IntelligenceBacklog of unresolved medical diagnoses leads to new method for clinical exome reanalysisStockT2 Biosystems to sell $8M in stock in private placementSponsor ContentVisit our Molecular Diagnostics Community